Noel J. Cusack

2.8k total citations
61 papers, 2.2k citations indexed

About

Noel J. Cusack is a scholar working on Physiology, Molecular Biology and Organic Chemistry. According to data from OpenAlex, Noel J. Cusack has authored 61 papers receiving a total of 2.2k indexed citations (citations by other indexed papers that have themselves been cited), including 33 papers in Physiology, 17 papers in Molecular Biology and 13 papers in Organic Chemistry. Recurrent topics in Noel J. Cusack's work include Adenosine and Purinergic Signaling (33 papers), Nitric Oxide and Endothelin Effects (11 papers) and Antiplatelet Therapy and Cardiovascular Diseases (9 papers). Noel J. Cusack is often cited by papers focused on Adenosine and Purinergic Signaling (33 papers), Nitric Oxide and Endothelin Effects (11 papers) and Antiplatelet Therapy and Cardiovascular Diseases (9 papers). Noel J. Cusack collaborates with scholars based in United Kingdom, United States and Mexico. Noel J. Cusack's co-authors include Susanna M.O. Hourani, S.M.O. Hourani, Jeremy D. Pearson, Laurence A. Welford, John L. Gordon, Colin B. Reese, Geoffrey Burnstock, Trevor J. Hallam, Tom Carter and Lindsey Needham and has published in prestigious journals such as Nature, Biochemical Journal and Pharmacological Reviews.

In The Last Decade

Noel J. Cusack

59 papers receiving 2.0k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Noel J. Cusack United Kingdom 29 1.3k 833 452 350 238 61 2.2k
J.M. Boeynaems Belgium 26 859 0.7× 882 1.1× 434 1.0× 197 0.6× 63 0.3× 55 2.1k
Gina H. Lu United States 21 594 0.5× 1.1k 1.4× 180 0.4× 371 1.1× 460 1.9× 32 2.0k
Bhalchandra V. Joshi United States 23 1.1k 0.8× 788 0.9× 189 0.4× 143 0.4× 435 1.8× 46 2.0k
Edward Leung Italy 24 1.1k 0.9× 1.0k 1.2× 156 0.3× 124 0.4× 364 1.5× 52 2.2k
S Angielski Poland 24 314 0.2× 997 1.2× 408 0.9× 213 0.6× 37 0.2× 145 2.3k
Margot W. Beukers Netherlands 27 849 0.7× 1.0k 1.2× 103 0.2× 77 0.2× 410 1.7× 42 1.9k
Johannes-Peter Stasch Germany 22 143 0.1× 1.0k 1.2× 1.3k 3.0× 918 2.6× 145 0.6× 31 2.7k
Per Arkhammar Sweden 30 232 0.2× 1.5k 1.7× 208 0.5× 107 0.3× 86 0.4× 59 2.4k
Daqing Sun China 17 192 0.1× 463 0.6× 143 0.3× 129 0.4× 173 0.7× 62 1.4k
Paolo Gelosa Italy 30 183 0.1× 930 1.1× 460 1.0× 364 1.0× 31 0.1× 51 2.9k

Countries citing papers authored by Noel J. Cusack

Since Specialization
Citations

This map shows the geographic impact of Noel J. Cusack's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Noel J. Cusack with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Noel J. Cusack more than expected).

Fields of papers citing papers by Noel J. Cusack

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Noel J. Cusack. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Noel J. Cusack. The network helps show where Noel J. Cusack may publish in the future.

Co-authorship network of co-authors of Noel J. Cusack

This figure shows the co-authorship network connecting the top 25 collaborators of Noel J. Cusack. A scholar is included among the top collaborators of Noel J. Cusack based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Noel J. Cusack. Noel J. Cusack is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Cusack, Noel J. & Susanna M.O. Hourani. (2000). Platelet P2 receptors: from curiosity to clinical targets. Journal of the Autonomic Nervous System. 81(1-3). 37–43. 19 indexed citations
3.
Cusack, Noel J. & Susanna M.O. Hourani. (1991). Design, Syntheses and Pharmacology of ATP Analogues Selective for Subtypes of P2-Purinoceptors. Nucleosides and Nucleotides. 10(5). 1019–1028. 4 indexed citations
4.
Cusack, Noel J. & Susanna M.O. Hourani. (1990). Subtypes of P2‐Purinoceptors. Annals of the New York Academy of Sciences. 603(1). 172–181. 54 indexed citations
5.
Pleass, Richard J., Noel J. Cusack, & John Westwick. (1990). An ATP receptor that mediates increases in intracellular calcium in U937 cells is a P2Y-purinoceptor. European Journal of Pharmacology. 183(4). 1605–1606. 3 indexed citations
6.
Shafi, Shahida, et al.. (1989). Increased uptake of methylated low-density lipoprotein induced by noradrenaline in carotid arteries of anaesthetized rabbits. Proceedings of the Royal Society of London. Series B, Biological sciences. 235(1281). 289–298. 28 indexed citations
7.
Stone, Trevor W. & Noel J. Cusack. (1989). Absence of P2‐purinoceptors in hippocampal pathways. British Journal of Pharmacology. 97(2). 631–635. 18 indexed citations
8.
McClure, Myra O., et al.. (1988). Evidence for the dependence of arterial haemostasis on ADP. Proceedings of the Royal Society of London. Series B, Biological sciences. 234(1276). 255–262. 16 indexed citations
9.
Tatham, Peter E.R., Noel J. Cusack, & Bastien D. Gomperts. (1988). Characterisation of the ATP4− receptor that mediates permeabilisation or rat mast cells. European Journal of Pharmacology. 147(1). 13–21. 79 indexed citations
10.
Carter, Tom, Trevor J. Hallam, Noel J. Cusack, & Jeremy D. Pearson. (1988). Regulation of P2y‐purinoceptor‐mediated prostacyclin release from human endothelial cells by cytoplasmic calcium concentration. British Journal of Pharmacology. 95(4). 1181–1190. 124 indexed citations
11.
Welford, Laurence A., Noel J. Cusack, & Susanna M.O. Hourani. (1987). The structure-activity relationships of ectonucleotidases and of excitatory P2-purinoceptors: evidence that dephosphorylation of ATP analogues reduces pharmacological potency. European Journal of Pharmacology. 141(1). 123–130. 115 indexed citations
12.
Pearson, Jeremy D., S. B. Coade, & Noel J. Cusack. (1985). Characterization of ectonucleotidases on vascular smooth-muscle cells. Biochemical Journal. 230(2). 503–507. 45 indexed citations
13.
Cusack, Noel J. & S.M.O. Hourani. (1984). Some pharmacological and biochemical interactions of the enantiomers of adenylyl 5′‐(β, γ‐methylene)‐diphosphonate with the guinea‐pig urinary bladder. British Journal of Pharmacology. 82(1). 155–159. 41 indexed citations
14.
Cusack, Noel J., Jeremy D. Pearson, & John L. Gordon. (1983). Stereoselectivity of ectonucleotidases on vascular endothelial cells. Biochemical Journal. 214(3). 975–981. 84 indexed citations
15.
Cusack, Noel J. & S.M.O. Hourani. (1982). ADENOSINE 5′‐DIPHOSPHATE ANTAGONISTS AND HUMAN PLATELETS: NO EVIDENCE THAT AGGREGATION AND INHIBITION OF STIMULATED ADENYLATE CYCLASE ARE MEDIATED BY DIFFERENT RECEPTORS. British Journal of Pharmacology. 76(1). 221–227. 67 indexed citations
16.
Brown, Christine M., Geoffrey Burnstock, Noel J. Cusack, Parviz Meghji, & Catherine J. Moody. (1982). EVIDENCE FOR STEREOSPECIFICITY OF THE P1‐PURINOCEPTOR. British Journal of Pharmacology. 75(1). 101–107. 29 indexed citations
17.
Cusack, Noel J.. (1980). Platelet-activating factor. Nature. 285(5762). 193–193. 34 indexed citations
18.
Cusack, Noel J., et al.. (1976). 2,4,6-Tri-isopropylbenzenesulphonyl hydrazide: A convenient source of di-imide. Tetrahedron. 32(17). 2157–2162. 111 indexed citations
19.
Cusack, Noel J., et al.. (1972). 2,4,6-Tri-isopropylbenzenesulphonyl hydrazide as a hydrogenating agent. Journal of the Chemical Society Chemical Communications. 1132–1132. 8 indexed citations
20.
Cusack, Noel J. & G. Shaw. (1970). A simple synthesis in high yield of 2,3-O-isopropylidene-β-D-ribofuranosylamine, an intermediate in the preparation of N-substituted ribofuranosides. Journal of the Chemical Society D Chemical Communications. 0(17). 1114–1114. 7 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026